Recent Advances in Nanomaterials Development for Nanomedicine and Cancer
- PMID: 35006909
- DOI: 10.1021/acsabm.1c00591
Recent Advances in Nanomaterials Development for Nanomedicine and Cancer
Abstract
Cancer is considered one of the leading causes of death, with a growing number of cases worldwide. However, the early diagnosis and efficient therapy of cancer have remained a critical challenge. The emergence of nanomedicine has opened up a promising window to address the drawbacks of cancer detection and treatment. A wide range of engineered nanomaterials and nanoplatforms with different shapes, sizes, and composition has been developed for various biomedical applications. Nanomaterials have been increasingly used in various applications in bioimaging, diagnosis, and therapy of cancers. Recently, numerous multifunctional and smart nanoparticles with the ability of simultaneous diagnosis and targeted cancer therapy have been reported. The multidisciplinary attempts led to the development of several exciting clinically approved nanotherapeutics. The nanobased materials and devices have also been used extensively to develop point-of-care and highly sensitive methods of cancer detection. In this review article, the most significant achievements and latest advances in the nanomaterials development for cancer nanomedicine are critically discussed. In addition, the future perspectives of this field are evaluated.
Keywords: cancer therapy; drug delivery; nanomaterials; nanomedicine; nanoparticles.
Similar articles
-
2D Nanomaterials for Cancer Theranostic Applications.Adv Mater. 2020 Apr;32(13):e1902333. doi: 10.1002/adma.201902333. Epub 2019 Jul 28. Adv Mater. 2020. PMID: 31353752 Review.
-
Recent Advances in Theranostic Applications of Nanomaterials in Cancer.Curr Pharm Des. 2022;28(2):133-150. doi: 10.2174/1381612827666210916140627. Curr Pharm Des. 2022. PMID: 34530703
-
Self-Assembled Organic Nanomaterials for Drug Delivery, Bioimaging, and Cancer Therapy.ACS Biomater Sci Eng. 2020 Sep 14;6(9):4816-4833. doi: 10.1021/acsbiomaterials.0c00883. Epub 2020 Aug 13. ACS Biomater Sci Eng. 2020. PMID: 33455214 Review.
-
Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.Acc Chem Res. 2011 Oct 18;44(10):1080-93. doi: 10.1021/ar200011r. Epub 2011 Jul 26. Acc Chem Res. 2011. PMID: 21786832 Review.
-
One-dimensional nanomaterials for cancer therapy and diagnosis.Chem Soc Rev. 2023 Jul 3;52(13):4488-4514. doi: 10.1039/d2cs00840h. Chem Soc Rev. 2023. PMID: 37338931 Review.
Cited by
-
Harnessing Biomaterials for Safeguarding Chimeric Antigen Receptor T Cell Therapy: An Artful Expedition in Mitigating Adverse Effects.Pharmaceuticals (Basel). 2024 Jan 22;17(1):139. doi: 10.3390/ph17010139. Pharmaceuticals (Basel). 2024. PMID: 38276012 Free PMC article. Review.
-
Riboflavin-citrate conjugate multicore SPIONs with enhanced magnetic responses and cellular uptake in breast cancer cells.Nanoscale Adv. 2022 Mar 2;4(8):1988-1998. doi: 10.1039/d2na00015f. eCollection 2022 Apr 12. Nanoscale Adv. 2022. PMID: 36133415 Free PMC article.
-
Dually Responsive Nanoparticles for Drug Delivery Based on Quaternized Chitosan.Int J Mol Sci. 2022 Jul 1;23(13):7342. doi: 10.3390/ijms23137342. Int J Mol Sci. 2022. PMID: 35806347 Free PMC article.
-
Manganese-derived biomaterials for tumor diagnosis and therapy.J Nanobiotechnology. 2024 Jun 15;22(1):335. doi: 10.1186/s12951-024-02629-8. J Nanobiotechnology. 2024. PMID: 38879519 Free PMC article.
-
Role of Paper-Based Sensors in Fight against Cancer for the Developing World.Biosensors (Basel). 2022 Sep 7;12(9):737. doi: 10.3390/bios12090737. Biosensors (Basel). 2022. PMID: 36140122 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Medical